Addition of the MSA1 signal and anchor sequences to the malaria merozoite surface antigen 1 C-terminal region enhances immunogenicity when expressed by recombinant vaccinia virus-Reference-Cited by-同舟云学术

Addition of the MSA1 signal and anchor sequences to the malaria merozoite surface antigen 1 C-terminal region enhances immunogenicity when expressed by recombinant vaccinia virus

Published:1997-08 Issue:12-13 Volume:15 Page:1303-1313
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Yang Shutong,Carroll Miles W.,Torres-Duarte Armida P.,Moss Bernard,Davidson Eugene A.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference46 articles.

1. Virological evidence for the success of the smallpox eradication programme;Arita;Nature,1979

2. Vaccinia virus: a selectable eukaryotic cloning and expression vector;Mackett,1982

3. Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus;Panicali,1982

4. Generation of recombinant vaccinia viruses;Earl;Curr. Protocols Molec. Biol.,1993

5. Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA;Smith;Gene,1983

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate;Frontiers in Immunology;2022-07-22

2. One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection;Proceedings of the National Academy of Sciences;2021-03-09

3. MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal Disease;2021-01-01

4. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host;Antiviral Research;2018-06

5. Enhancing poxvirus vectors vaccine immunogenicity;Human Vaccines & Immunotherapeutics;2014-05-05